Cargando…
Lef1 restricts ectopic crypt formation and tumor cell growth in intestinal adenomas
Somatic mutations in APC or CTNNB1 genes lead to aberrant Wnt signaling and colorectal cancer (CRC) initiation and progression via-catenin–T cell factor/lymphoid enhancer binding factor TCF/LEF transcription factors. We found that Lef1 was expressed exclusively in Apc-mutant, Wnt ligand–independent...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8598008/ https://www.ncbi.nlm.nih.gov/pubmed/34788095 http://dx.doi.org/10.1126/sciadv.abj0512 |
_version_ | 1784600718143913984 |
---|---|
author | Heino, Sarika Fang, Shentong Lähde, Marianne Högström, Jenny Nassiri, Sina Campbell, Andrew Flanagan, Dustin Raven, Alexander Hodder, Michael Nasreddin, Nadia Xue, Hai-Hui Delorenzi, Mauro Leedham, Simon Petrova, Tatiana V. Sansom, Owen Alitalo, Kari |
author_facet | Heino, Sarika Fang, Shentong Lähde, Marianne Högström, Jenny Nassiri, Sina Campbell, Andrew Flanagan, Dustin Raven, Alexander Hodder, Michael Nasreddin, Nadia Xue, Hai-Hui Delorenzi, Mauro Leedham, Simon Petrova, Tatiana V. Sansom, Owen Alitalo, Kari |
author_sort | Heino, Sarika |
collection | PubMed |
description | Somatic mutations in APC or CTNNB1 genes lead to aberrant Wnt signaling and colorectal cancer (CRC) initiation and progression via-catenin–T cell factor/lymphoid enhancer binding factor TCF/LEF transcription factors. We found that Lef1 was expressed exclusively in Apc-mutant, Wnt ligand–independent tumors, but not in ligand-dependent, serrated tumors. To analyze Lef1 function in tumor development, we conditionally deleted Lef1 in intestinal stem cells of Apc(fl/fl) mice or broadly from the entire intestinal epithelium of Apc(fl/fl) or Apc(Min/+) mice. Loss of Lef1 markedly increased tumor initiation and tumor cell proliferation, reduced the expression of several Wnt antagonists, and increased Myc proto-oncogene expression and formation of ectopic crypts in Apc-mutant adenomas. Our results uncover a previously unknown negative feedback mechanism in CRC, in which ectopic Lef1 expression suppresses intestinal tumorigenesis by restricting adenoma cell dedifferentiation to a crypt-progenitor phenotype and by reducing the formation of cancer stem cell niches. |
format | Online Article Text |
id | pubmed-8598008 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | American Association for the Advancement of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-85980082021-11-29 Lef1 restricts ectopic crypt formation and tumor cell growth in intestinal adenomas Heino, Sarika Fang, Shentong Lähde, Marianne Högström, Jenny Nassiri, Sina Campbell, Andrew Flanagan, Dustin Raven, Alexander Hodder, Michael Nasreddin, Nadia Xue, Hai-Hui Delorenzi, Mauro Leedham, Simon Petrova, Tatiana V. Sansom, Owen Alitalo, Kari Sci Adv Biomedicine and Life Sciences Somatic mutations in APC or CTNNB1 genes lead to aberrant Wnt signaling and colorectal cancer (CRC) initiation and progression via-catenin–T cell factor/lymphoid enhancer binding factor TCF/LEF transcription factors. We found that Lef1 was expressed exclusively in Apc-mutant, Wnt ligand–independent tumors, but not in ligand-dependent, serrated tumors. To analyze Lef1 function in tumor development, we conditionally deleted Lef1 in intestinal stem cells of Apc(fl/fl) mice or broadly from the entire intestinal epithelium of Apc(fl/fl) or Apc(Min/+) mice. Loss of Lef1 markedly increased tumor initiation and tumor cell proliferation, reduced the expression of several Wnt antagonists, and increased Myc proto-oncogene expression and formation of ectopic crypts in Apc-mutant adenomas. Our results uncover a previously unknown negative feedback mechanism in CRC, in which ectopic Lef1 expression suppresses intestinal tumorigenesis by restricting adenoma cell dedifferentiation to a crypt-progenitor phenotype and by reducing the formation of cancer stem cell niches. American Association for the Advancement of Science 2021-11-17 /pmc/articles/PMC8598008/ /pubmed/34788095 http://dx.doi.org/10.1126/sciadv.abj0512 Text en Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution License 4.0 (CC BY). https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution license (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Biomedicine and Life Sciences Heino, Sarika Fang, Shentong Lähde, Marianne Högström, Jenny Nassiri, Sina Campbell, Andrew Flanagan, Dustin Raven, Alexander Hodder, Michael Nasreddin, Nadia Xue, Hai-Hui Delorenzi, Mauro Leedham, Simon Petrova, Tatiana V. Sansom, Owen Alitalo, Kari Lef1 restricts ectopic crypt formation and tumor cell growth in intestinal adenomas |
title | Lef1 restricts ectopic crypt formation and tumor cell growth in intestinal adenomas |
title_full | Lef1 restricts ectopic crypt formation and tumor cell growth in intestinal adenomas |
title_fullStr | Lef1 restricts ectopic crypt formation and tumor cell growth in intestinal adenomas |
title_full_unstemmed | Lef1 restricts ectopic crypt formation and tumor cell growth in intestinal adenomas |
title_short | Lef1 restricts ectopic crypt formation and tumor cell growth in intestinal adenomas |
title_sort | lef1 restricts ectopic crypt formation and tumor cell growth in intestinal adenomas |
topic | Biomedicine and Life Sciences |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8598008/ https://www.ncbi.nlm.nih.gov/pubmed/34788095 http://dx.doi.org/10.1126/sciadv.abj0512 |
work_keys_str_mv | AT heinosarika lef1restrictsectopiccryptformationandtumorcellgrowthinintestinaladenomas AT fangshentong lef1restrictsectopiccryptformationandtumorcellgrowthinintestinaladenomas AT lahdemarianne lef1restrictsectopiccryptformationandtumorcellgrowthinintestinaladenomas AT hogstromjenny lef1restrictsectopiccryptformationandtumorcellgrowthinintestinaladenomas AT nassirisina lef1restrictsectopiccryptformationandtumorcellgrowthinintestinaladenomas AT campbellandrew lef1restrictsectopiccryptformationandtumorcellgrowthinintestinaladenomas AT flanagandustin lef1restrictsectopiccryptformationandtumorcellgrowthinintestinaladenomas AT ravenalexander lef1restrictsectopiccryptformationandtumorcellgrowthinintestinaladenomas AT hoddermichael lef1restrictsectopiccryptformationandtumorcellgrowthinintestinaladenomas AT nasreddinnadia lef1restrictsectopiccryptformationandtumorcellgrowthinintestinaladenomas AT xuehaihui lef1restrictsectopiccryptformationandtumorcellgrowthinintestinaladenomas AT delorenzimauro lef1restrictsectopiccryptformationandtumorcellgrowthinintestinaladenomas AT leedhamsimon lef1restrictsectopiccryptformationandtumorcellgrowthinintestinaladenomas AT petrovatatianav lef1restrictsectopiccryptformationandtumorcellgrowthinintestinaladenomas AT sansomowen lef1restrictsectopiccryptformationandtumorcellgrowthinintestinaladenomas AT alitalokari lef1restrictsectopiccryptformationandtumorcellgrowthinintestinaladenomas |